News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI Thinks Like Us – Flaws and All: New Study Finds ChatGPT Mirrors Human Decision Biases in Half the Tests
News Release

BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations showing biases like overconfidence of hot-hand (gambler’s) fallacy yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Read More
In 2025, you can’t have an effective democracy without data literacy
Media Coverage

You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.

Read More
Shell Shocked: How Small Eateries Are Dealing With Record Egg Prices
Media Coverage

Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
States Craft Vaccine Plans in a Haze of Changing Information

States Craft Vaccine Plans in a Haze of Changing Information

Bloomberg, December 4, 2020

Weeks before states expect to receive their first shipments of Covid-19 vaccines, conflicting messages from the federal government have obscured exactly how many doses may arrive. Some governors, including New York’s Andrew Cuomo and California’s Gavin Newsom, have made splashy announcements about how much of Pfizer Inc. and BioNTech SE’s vaccines they expect should the U.S. Food and Drug Administration authorize them this month. Other states can’t provide a solid answer given how quickly estimates change

Minnesota-Based Company Will Protect COVID-19 Vaccines on Supply Chains

Minnesota-Based Company Will Protect COVID-19 Vaccines on Supply Chains

Kare, December 3, 2020

Shortly before World War II, Minnesota-based U.S. Thermo Control Company introduced the revolutionary concept of transport refrigeration to the world, allowing trucks to haul frozen foods and perishables to every corner of the United States. The company, co-founded by renowned inventor Frederick McKinley Jones and businessman Joseph Numero, helped store items at controlled temperatures as they crossed “through mountain blizzards and desert heat,” according to a May 1950 article in the Minneapolis Sunday Tribune. During the war, these refrigeration units “kept food fresh on island bases and dropped into steaming jungle with parachute troops.” 

Fact Check: Did North Carolina Voting Sites Have Any Clusters of COVID-19 Cases?

Fact Check: Did North Carolina Voting Sites Have Any Clusters of COVID-19 Cases?

The Charlotte Observer, December 4, 2020

Karen Brinson Bell, executive director of the North Carolina State Board of Elections, said Nov. 24 that no spread of COVID-19 had been linked to voting in North Carolina. The NCSBE also said in a news release that there have been zero clusters of COVID-19 connected to voting sites in North Carolina. Are these claims accurate, and what counts as a “cluster”? Does that mean there weren’t any coronavirus cases connected to voting at all?

What's Driving Coronavirus Vaccine Hesitancy in US?

What's Driving Coronavirus Vaccine Hesitancy in US?

Fox News, December 3, 2020

The United States is potentially days away from approving the first round of coronavirus vaccines just nine months after the global pandemic ripped through every state, claimed hundreds of thousands of lives and crippled the once robust economy. And yet, millions have vowed not to take the fast-developed two-shot vaccines despite 95% efficacy rates from pharmaceutical companies Pfizer and BioNTech and another from Moderna. Why the hesitancy and how long could the COVID-19 crisis continue as a result?

States Craft Vaccine Plans in a Haze of Changing Information

States Craft Vaccine Plans in a Haze of Changing Information

Bloomberg Quint, December 4, 2020

Weeks before states expect to receive their first shipments of Covid-19 vaccines, conflicting messages from the federal government have obscured exactly how many doses may arrive. Some governors, including New York’s Andrew Cuomo and California’s Gavin Newsom, have made splashy announcements about how much of Pfizer Inc. and BioNTech SE’s vaccines they expect should the U.S. Food and Drug Administration authorize them this month. Other states can’t provide a solid answer given how quickly estimates change.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine